BioDelivery Sciences International, Inc. · Raleigh, NC United States (NASDAQ: BDSI)
| 801 Corporate Center Drive, Suite 210 | Phone: 919-582-9050 |
| Raleigh, NC | Fax: 919-582-9051 |
| 27607 | |
| United States | 
Map This Company |
BioDelivery Sciences International, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
BioDelivery Sciences International isn't inventing new drugs, but it is looking for better ways to administer them. The development-stage firm takes already approved drugs that are normally delivered intravenously and reformulates them into buccal (absorbed by the inner cheek) and oral treatments. Drugs delivered via its BEMA and Bioral systems are being studied to treat such conditions as acute pain, nausea, and fungal infections. In 2009 BioDelivery Sciences gained
BioDelivery Sciences International, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: BDSI Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 18 |
Executives
17 executives listed for BioDelivery Sciences International, Inc.'s Raleigh, NC location.
| Chairman | Francis O'Donnell | |
|---|---|---|
| President, CEO, and Director | Mark Sirgo | |
| CFO, Secretary, and Treasurer | James McNulty |